Continuous Glucose Monitors and the Role they Play in the Management of Diabetes Mellitus

By: Emily Lammers, PharmD, MSLD; PGY2 Ambulatory Care/Academia Resident

Mentor: Lisa Cillessen, PharmD, BCACP; Clinical Assistant Professor, UMKC School of Pharmacy at MSU

Program Number: 2021-03-02

Approval Dates: April 7, 2021 to October 1, 2021

Approved Contact Hours: 1 hour

Read Full Article & Take CE Quiz

Pumped Up About SGLT2 Inhibitor Use in Heart Failure

By Sarah Lothspeich, PharmD, MPH; PGY2 Ambulatory Care Resident, CoxHealth - Springfield

Program Number: 2021-03-03

Approval Dates: April 7, 2021 to October 1, 2021

Approved Contact Hours: 1 hour

Read Full Article & Take CE Quiz

Brexanolone for the Treatment of Postpartum Depression

Author: Bridgette McCauley, PharmD; PGY-2 Psychiatry Pharmacy Practice Resident

Mentor: O. Greg Deardorff, PharmD, BCPP; Clinical Pharmacy Manager, Fulton State Hospital – Fulton, MO

Program Number: 2021-01-03

Approval Dates: February 3, 2021 to August 1, 2021

Approved Contact Hours: 1 hour

Read Full Article & Take CE Quiz

Review of Semaglutide, the First Oral GLP-1 Receptor Agonist

Author: Rachel Kiehne, PharmD; PGY2 Ambulatory Care Resident

Mentor: Justinne Guyton, PharmD, BCACP, PGY2 Ambulatory Care Residency Director and Associate Professor, St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis/St. Louis County Department of Public Health

Program Number: 2021-01-04

Approval Dates: February 3, 2021 to August 1, 2021

Approved Contact Hours: 1 hour

Read Full Article & Take CE Quiz

Therapeutic Challenges to Treating Sodium Disorders: A Review of Hyponatremia and Hypernatremia

Author: Gadison Quick, PharmD; PGY1 Pharmacy Resident

Mentor: Kerry Yamada, PharmD, BCPS; PGY-1 Pharmacy Residency Coordinator, Truman Medical Center – Kansas City, Mo

Program Number: 2020-11-01

Approval Dates: December 1, 2020 to May 1, 2021

Approved Contact Hours: 1 hour

Read Full Article & Take CE Quiz